How to contact the center
HCP Center
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/necker-430x160.jpeg)
as part of the Rare Diseases Plan 2006-2011, re-labeling in 2017. OPHTARA is
unique consortium part of ERN-EYE with 5 Paris University Hospital sites: Necker
(Coordinator site), Pitié Salpetrière, HEGP, Cochin and Hôtel Dieu (component sites).
Picture : Celette
Contact
OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France
Team
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/bremont-230x230.jpg)
Pr Dominique BREMOND-GIGNAC
France
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/telechargement.jpeg)
Dr Alejandra Daruich-Matet
France
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/photo_identite_matthieu_robert_copie-230x230.jpg)
Pr Matthieu Robert
France
Clinical trials
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients From 6 Months to Less Than 2 Years Old
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis (NEF-1)
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
An International Prospective Natural History Study in Children With a Type II Collagen Disorder With Short Stature
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy.
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.